Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1961-9987
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage? ; volume:27 ; number:1 ; day:17 ; month:3 ; year:2021 ; pages:1-6 ; date:12.2021
African journal of urology ; 27, Heft 1 (17.3.2021), 1-6, 12.2021
- Creator
-
Abou Heidar, Nassib
Labban, Muhieddine Saadeddine
Armache, Alexandre Khalil
Bulbul, Muhammad Ahmad
El-Hajj, Albert Elias
Khauli, Raja Bahjat
Nasr, Rami
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12301-021-00151-z
- URN
-
urn:nbn:de:101:1-2021050420270923761288
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abou Heidar, Nassib
- Labban, Muhieddine Saadeddine
- Armache, Alexandre Khalil
- Bulbul, Muhammad Ahmad
- El-Hajj, Albert Elias
- Khauli, Raja Bahjat
- Nasr, Rami
- SpringerLink (Online service)
Other Objects (12)
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Bacille Calmette-Guérin Supply Disruption Emphasizes the Importance of Stewardship
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Bacille Calmette-Guérin Supply Disruption Emphasizes the Importance of Stewardship
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency